Skip Nav Destination

Issues

Select Decade

Select Year

Issue

Volume 121, Issue 2-3

June 2009

All Issues

Cover Image

Cover Image

ISSN 0001-5792

EISSN 1421-9662

In this Issue

Special Section
Paper
Further Section

Acta Haematologica 2009, Vol. 121, No. 2-3

Special Section

Title Page / Table of Contents

Subject Area: Hematology , Oncology

Acta Haematol (2009) 121 (2-3): 67–70. https://doi.org/10.1159/000224711

View articletitled, Title Page / Table of Contents

Open the PDF for in another window

Paper

Laboratory Diagnosis and Molecular Classification of von Willebrand Disease

Subject Area: Hematology , Oncology

Alain Gadisseur; Cedric Hermans; Zwi Berneman; Wilfried Schroyens; Hans Deckmyn; Jan Jacques Michiels

Acta Haematol (2009) 121 (2-3): 71–84. https://doi.org/10.1159/000214846

Abstract

View articletitled, Laboratory Diagnosis and Molecular Classification of von Willebrand Disease

Open the PDF for in another window

Laboratory Diagnosis and Molecular Basis of Mild von Willebrand Disease Type 1

Subject Area: Hematology , Oncology

Jan Jacques Michiels; Zwi Berneman; Alain Gadisseur; Marc van der Planken; Wilfried Schroyens; Huub H.D.M. van Vliet

Acta Haematol (2009) 121 (2-3): 85–97. https://doi.org/10.1159/000214847

Abstract

View articletitled, Laboratory Diagnosis and Molecular Basis of Mild von Willebrand Disease Type 1

Open the PDF for in another window

C1584: Effect on von Willebrand Factor Proteolysis and von Willebrand Factor Antigen Levels

Subject Area: Hematology , Oncology

James Anthony Davies; Peter William Collins; Lee Sarah Hathaway; Derrick John Bowen

Acta Haematol (2009) 121 (2-3): 98–101. https://doi.org/10.1159/000214848

Abstract

View articletitled, C1584: Effect on von Willebrand Factor Proteolysis and von Willebrand Factor Antigen Levels

Open the PDF for in another window

Factor VIII-von Willebrand Factor Binding Defects in Autosomal Recessive von Willebrand Disease Type Normandy and in Mild Hemophilia A: New Insights into Factor VIII-von Willebrand Factor Interactions

Subject Area: Hematology , Oncology

Marc Jacquemin

Acta Haematol (2009) 121 (2-3): 102–105. https://doi.org/10.1159/000214849

Abstract

View articletitled, Factor VIII-von Willebrand Factor Binding Defects in Autosomal Recessive von Willebrand Disease Type Normandy and in Mild Hemophilia A: New Insights into Factor VIII-von Willebrand Factor Interactions

Open the PDF for in another window

Autosomal Recessive von Willebrand Disease Type 1 or 2 due to Homozygous or Compound Heterozygous Mutations in the von Willebrand Factor Gene: A Single Center Experience on Molecular Heterogeneity and Laboratory Features in 12 Families

Subject Area: Hematology , Oncology

G. Castaman; S. Giacomelli; F. Rodeghiero

Acta Haematol (2009) 121 (2-3): 106–110. https://doi.org/10.1159/000214850

Abstract

View articletitled, Autosomal Recessive von Willebrand Disease Type 1 or 2 due to Homozygous or Compound Heterozygous Mutations in the von Willebrand Factor Gene: A Single Center Experience on Molecular Heterogeneity and Laboratory Features in 12 Families

Open the PDF for in another window

Laboratory and Molecular Characteristics of Recessive von Willebrand Disease Type 2C (2A Subtype IIC) of Variable Severity due to Homozygous or Double Heterozygous Mutations in the D1 and D2 Domains

Subject Area: Hematology , Oncology

Jan Jacques Michiels; Alain Gadisseur; Marc van der Planken; Wilfried Schroyens; Zwi Berneman

Acta Haematol (2009) 121 (2-3): 111–118. https://doi.org/10.1159/000214851

Abstract

View articletitled, Laboratory and Molecular Characteristics of Recessive von Willebrand Disease Type 2C (2A Subtype IIC) of Variable Severity due to Homozygous or Double Heterozygous Mutations in the D1 and D2 Domains

Open the PDF for in another window

Recessive von Willebrand Disease Type 2 Normandy: Variable Expression of Mild Hemophilia and VWD Type 1

Subject Area: Hematology , Oncology

Jan Jacques Michiels; Alain Gadisseur; Inge Vangenegten; Wilfried Schroyens; Zwi Berneman

Acta Haematol (2009) 121 (2-3): 119–127. https://doi.org/10.1159/000214852

Abstract

View articletitled, Recessive von Willebrand Disease Type 2 Normandy: Variable Expression of Mild Hemophilia and VWD Type 1

Open the PDF for in another window

Laboratory Diagnosis of von Willebrand Disease Type 1/2E (2A Subtype IIE), Type 1 Vicenza and Mild Type 1 Caused by Mutations in the D3, D4, B1–B3 and C1–C2 Domains of the von Willebrand Factor Gene: Role of von Willebrand Factor Multimers and the von Willebrand Factor Propeptide/Antigen Ratio

Subject Area: Hematology , Oncology

Alain Gadisseur; Zwi Berneman; Wilfried Schroyens; Jan Jacques Michiels

Acta Haematol (2009) 121 (2-3): 128–138. https://doi.org/10.1159/000214853

Abstract

View articletitled, Laboratory Diagnosis of von Willebrand Disease Type 1/2E (2A Subtype IIE), Type 1 Vicenza and Mild Type 1 Caused by Mutations in the D3, D4, B1–B3 and C1–C2 Domains of the von Willebrand Factor Gene: Role of von Willebrand Factor Multimers and the von Willebrand Factor Propeptide/Antigen Ratio

Open the PDF for in another window

Autosomal Dominant von Willebrand Disease Type 2M

Subject Area: Hematology , Oncology

Cedric Hermans; Javier Batlle

Acta Haematol (2009) 121 (2-3): 139–144. https://doi.org/10.1159/000214854

Abstract

View articletitled, Autosomal Dominant von Willebrand Disease Type 2M

Open the PDF for in another window

Dominant von Willebrand Disease Type 2M and 2U Are Variable Expressions of One Distinct Disease Entity Caused by Loss-of-Function Mutations in the A1 Domain of the von Willebrand Factor Gene

Subject Area: Hematology , Oncology

Alain Gadisseur; Marc van der Planken; Wilfried Schroyens; Zwi Berneman; Jan Jacques Michiels

Acta Haematol (2009) 121 (2-3): 145–153. https://doi.org/10.1159/000214855

Abstract

View articletitled, Dominant von Willebrand Disease Type 2M and 2U Are Variable Expressions of One Distinct Disease Entity Caused by Loss-of-Function Mutations in the A1 Domain of the von Willebrand Factor Gene

Open the PDF for in another window

Dominant von Willebrand Disease Type 2A Groups I and II due to Missense Mutations in the A2 Domain of the von Willebrand Factor Gene: Diagnosis and Management

Subject Area: Hematology , Oncology

Jan Jacques Michiels; Huub H.D.M. van Vliet

Acta Haematol (2009) 121 (2-3): 154–166. https://doi.org/10.1159/000214856

Abstract

View articletitled, Dominant von Willebrand Disease Type 2A Groups I and II due to Missense Mutations in the A2 Domain of the von Willebrand Factor Gene: Diagnosis and Management

Open the PDF for in another window

Managing Patients with von Willebrand Disease Type 1, 2 and 3 with Desmopressin and von Willebrand Factor-Factor VIII Concentrate in Surgical Settings

Subject Area: Hematology , Oncology

Jan Jacques Michiels; Huub H.D.M. van Vliet; Zwi Berneman; Wilfried Schroyens; Alain Gadisseur

Acta Haematol (2009) 121 (2-3): 167–176. https://doi.org/10.1159/000214857

Abstract

View articletitled, Managing Patients with von Willebrand Disease Type 1, 2 and 3 with Desmopressin and von Willebrand Factor-Factor VIII Concentrate in Surgical Settings

Open the PDF for in another window

Causes, Etiology and Diagnosis of Acquired von Willebrand Disease: A Prospective Diagnostic Workup to Establish the Most Effective Therapeutic Strategies

Subject Area: Hematology , Oncology

Christoph Sucker; Jan Jacques Michiels; Rainer B. Zotz

Acta Haematol (2009) 121 (2-3): 177–182. https://doi.org/10.1159/000214858

Abstract

View articletitled, Causes, Etiology and Diagnosis of Acquired von Willebrand Disease: A Prospective Diagnostic Workup to Establish the Most Effective Therapeutic Strategies

Open the PDF for in another window

ADAMTS13 in Health and Disease

Subject Area: Hematology , Oncology

Hendrik B. Feys; Hans Deckmyn; Karen Vanhoorelbeke

Acta Haematol (2009) 121 (2-3): 183–185. https://doi.org/10.1159/000214859

Abstract

View articletitled, ADAMTS13 in Health and Disease

Open the PDF for in another window

Further Section

Author and Subject Index Vol. 121, No. 2–3, 2009

Subject Area: Hematology , Oncology

Acta Haematol (2009) 121 (2-3): 186. https://doi.org/10.1159/000224713

View articletitled, Author and Subject Index Vol. 121, No. 2–3, 2009

Open the PDF for in another window

Email alerts

Online First Alert

Latest Issue Alert

Latest
Most Read
Most Cited

Machine learning for the prediction of survival post-allogeneic hematopoietic cell transplantation: A single-center experience: Machine learning for prediction in allogeneic HCT

Intermittent high-dose glucocorticoid treatment does not cause adrenal insufficiency in patients with diffuse large B-cell lymphoma - a prospective study

Limited efficacy of Venetoclax Combination Regimens in Acute Myeloid Leukemia with Extramedullary Relapse

Evidence-based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf Region: CLL management consensus in the Gulf

RSS

Current Issue RSS Feed

Open Issues RSS Feed

Acta Haematologica 2009, Vol. 121, No. 2-3

Special Section

Title Page / Table of Contents

Paper

Laboratory Diagnosis and Molecular Classification of von Willebrand Disease

Laboratory Diagnosis and Molecular Basis of Mild von Willebrand Disease Type 1

C1584: Effect on von Willebrand Factor Proteolysis and von Willebrand Factor Antigen Levels

Factor VIII-von Willebrand Factor Binding Defects in Autosomal Recessive von Willebrand Disease Type Normandy and in Mild Hemophilia A: New Insights into Factor VIII-von Willebrand Factor Interactions

Autosomal Recessive von Willebrand Disease Type 1 or 2 due to Homozygous or Compound Heterozygous Mutations in the von Willebrand Factor Gene: A Single Center Experience on Molecular Heterogeneity and Laboratory Features in 12 Families

Laboratory and Molecular Characteristics of Recessive von Willebrand Disease Type 2C (2A Subtype IIC) of Variable Severity due to Homozygous or Double Heterozygous Mutations in the D1 and D2 Domains

Recessive von Willebrand Disease Type 2 Normandy: Variable Expression of Mild Hemophilia and VWD Type 1

Laboratory Diagnosis of von Willebrand Disease Type 1/2E (2A Subtype IIE), Type 1 Vicenza and Mild Type 1 Caused by Mutations in the D3, D4, B1–B3 and C1–C2 Domains of the von Willebrand Factor Gene: Role of von Willebrand Factor Multimers and the von Willebrand Factor Propeptide/Antigen Ratio

Autosomal Dominant von Willebrand Disease Type 2M

Dominant von Willebrand Disease Type 2M and 2U Are Variable Expressions of One Distinct Disease Entity Caused by Loss-of-Function Mutations in the A1 Domain of the von Willebrand Factor Gene

Dominant von Willebrand Disease Type 2A Groups I and II due to Missense Mutations in the A2 Domain of the von Willebrand Factor Gene: Diagnosis and Management

Managing Patients with von Willebrand Disease Type 1, 2 and 3 with Desmopressin and von Willebrand Factor-Factor VIII Concentrate in Surgical Settings

Causes, Etiology and Diagnosis of Acquired von Willebrand Disease: A Prospective Diagnostic Workup to Establish the Most Effective Therapeutic Strategies

ADAMTS13 in Health and Disease

Further Section

Author and Subject Index Vol. 121, No. 2–3, 2009

Email alerts

RSS

INFORMATION

ABOUT US

SERVICES FOR

Karger International

Issues

Cover Image

Acta Haematologica 2009, Vol. 121, No. 2-3

Special Section

Paper

Further Section

Email alerts

RSS

This Feature Is Available To Subscribers Only